Section archive
Healthcare
Healthcare
HHS Renews COVID-19 Public Health Emergency for Another 90 Days as Federal Flexibilities Remain in Place
Healthcare
FDA Grants Accelerated Approval to Leqembi for Early Alzheimer’s, Pairing Amyloid Reduction With New Safety and Access Questions
Healthcare
U.S. Orders COVID-19 Tests for Travelers From China as Officials Cite Data Gaps and Variant Surveillance
Healthcare
FDA Approves Actemra for Hospitalized Adults With Severe COVID-19 After RECOVERY Shows 29% vs. 33% 28-Day Mortality
Healthcare
FDA Grants Accelerated Approval to Krazati After 42.9% Response Rate in KRAS G12C-Mutated Lung Cancer
Healthcare
FDA, CDC Expand Updated COVID-19 Vaccines to Children 6 Months and Older as Winter Campaign Broadens
Healthcare
Lecanemab Slows Early Alzheimer’s Decline 27% in 1,795-Patient Phase 3 Trial, With ARIA-E Seen in 12.6%
Healthcare
FDA Approves Hemgenix, First U.S. Gene Therapy for Hemophilia B, as One-Time Infusion Reduces Bleeding
Healthcare
FDA Approves Tzield as First Drug to Delay Type 1 Diabetes, Using 14-Day Infusion Before Clinical Disease
Healthcare
Flu Hospitalization Rate Reaches 5.0 per 100,000 by Early November, Highest at This Point Since 2010–11
Healthcare
Pfizer Maternal RSV Vaccine Cuts Severe Infant Illness 81.8% in First 90 Days in Phase 3 Interim Analysis
Healthcare
Flu Hospitalizations Reach Highest Early-Season Level in a Decade as U.S. Activity Accelerates
Healthcare
CDC Allows Novavax as First COVID Booster for Adults Who Cannot or Will Not Take mRNA Shots
Healthcare
FDA and CDC Expand Omicron-Targeted COVID Boosters to Children as Young as 5
Healthcare
Flu Activity Starts Rising Early as CDC Finds 2.5% Test Positivity and Influenza A Dominates U.S. Surveillance
Healthcare
FDA Approves Relyvrio for ALS After 137-Patient Trial and Divided Review, Adding First New U.S. Treatment Since 2017
Healthcare
Biden Says ‘Pandemic Is Over’ as Federal COVID Emergency, 400 Daily Deaths and Fall Booster Campaign Continue
215 stories